BMJ 2005;330:18-19 (1 January), doi:10.1136/bmj.38301.657014.79 (published 25 November 2004)
Paper
Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data
Heikki Peltola, professor of infectious diseases1,
Eeva Salo, consultant of pediatric infectious diseases1,
Harri Saxén, consultant of pediatric infectious diseases1
1 Helsinki University Children's Hospital, Hospital for Children and Adolescents, PO Box 281, 00029 HUS, Helsinki, Finland
Correspondence to: H Peltola heikki.peltola@hus.fi
| The first 150 words of the full text of this article appear below. |
Introduction
Despite the spectacular success of
Haemophilus influenzae type
b (Hib) conjugate vaccines in the developed world,
1 failures
have become more common in the Netherlands and the United Kingdom,
where the incidence of invasive Hib diseases at age 0-4 years
per 100 000 increased from 0.66 in 1998 to 2.96 in 2001.
2 An
immunological defect is not to blame.
This increase in failure coincided with the change from whole cell pertussis to combined three component acellular vaccine (DTaP-Hib). This combination lowers Hib antibodies.3 The clinical significance is unclear. Acellular vaccine cannot be blamed in the Netherlands, where whole cell vaccine was still used.4 Both countries have been giving Hib vaccination at age 2, 3, and 4 months; a booster at 11 months is given in the Netherlands. Another characteristic in the United Kingdom is concomitant meningococcal group C conjugate. Replacement of serotypes other than Hib in severe diseases has also raised . . . [Full text of this article]
Methods and results
Comment

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Kanegaye, J. T., Nigrovic, L. E., Malley, R., Cannavino, C. R., Schwab, S. H., Bennett, J. E., Mohseni, M. M., Wang, V. J., Katsogridakis, Y. L., Herman, M. I., Kuppermann, N., for the American Academy of Pediatrics, Pediatric,
(2009). Diagnostic Value of Immature Neutrophils (Bands) in the Cerebrospinal Fluid of Children With Cerebrospinal Fluid Pleocytosis. Pediatrics
123: e967-e971
[Abstract]
[Full text]
-
Kimia, A. A., Capraro, A. J., Hummel, D., Johnston, P., Harper, M. B.
(2009). Utility of Lumbar Puncture for First Simple Febrile Seizure Among Children 6 to 18 Months of Age. Pediatrics
123: 6-12
[Abstract]
[Full text]
-
Nigrovic, L. E., Kuppermann, N., Macias, C. G., Cannavino, C. R., Moro-Sutherland, D. M., Schremmer, R. D., Schwab, S. H., Agrawal, D., Mansour, K. M., Bennett, J. E., Katsogridakis, Y. L., Mohseni, M. M., Bulloch, B., Steele, D. W., Kaplan, R. L., Herman, M. I., Bandyopadhyay, S., Dayan, P., Truong, U. T., Wang, V. J., Bonsu, B. K., Chapman, J. L., Kanegaye, J. T., Malley, R., for the Pediatric Emergency Medicine Collaborative,
(2007). Clinical Prediction Rule for Identifying Children With Cerebrospinal Fluid Pleocytosis at Very Low Risk of Bacterial Meningitis. JAMA
297: 52-60
[Abstract]
[Full text]
-
Finn, A, Heath, P
(2005). Conjugate vaccines. Arch. Dis. Child.
90: 667-669
[Full text]
Rapid Responses:
Read all Rapid Responses
- Epidemiological Data are Essential
- Mary E Ramsay, et al.
bmj.com, 16 Dec 2004
[Full text]
- What is already known on this topic
- Arun K Mukerjee
bmj.com, 11 Jan 2005
[Full text]